Bio Preventive Medicine Corp

ROCO:6810 (Taiwan)  
NT$ 38.10 (0%) May 24
At Loss
P/B:
9.43
Market Cap:
NT$ 1.32B ($ 40.95M)
Enterprise V:
NT$ 1.35B ($ 41.94M)
Volume:
10.33K
Avg Vol (2M):
79.00K
Volume:
10.33K
At Loss
Avg Vol (2M):
79.00K

Business Description

Description
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.
Name Current Vs Industry Vs History
Cash-To-Debt 0.72
Equity-to-Asset 0.53
Debt-to-Equity 0.81
Debt-to-EBITDA -1.82
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.55
Distress
Grey
Safe
Beneish M-Score -3.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 46.31
9-Day RSI 50.37
14-Day RSI 51.36
6-1 Month Momentum % -5.61
12-1 Month Momentum % -4.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.09
Quick Ratio 5.02
Cash Ratio 4.42
Days Inventory 3643.19
Days Sales Outstanding 34.65
Days Payable 441.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.4
Shareholder Yield % -9.45
Name Current Vs Industry Vs History
Gross Margin % 89.65
Operating Margin % -6006.95
Net Margin % -6066.64
FCF Margin % -5435.1
ROE % -47.96
ROA % -26.15
ROIC % -39.77
ROC (Joel Greenblatt) % -43.67
ROCE % -26.87

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 1087.15
PB Ratio 9.43
Price-to-Tangible-Book 10.5
EV-to-EBIT -19.14
EV-to-EBITDA -21.66
EV-to-Revenue 1118.12
EV-to-FCF -20.73
Earnings Yield (Greenblatt) % -5.23
FCF Yield % -4.98

Financials

ROCO:6810's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bio Preventive Medicine Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 1.208
EPS (TTM) (NT$) -2.151
Beta 0
Volatility % 14.61
14-Day RSI 51.36
14-Day ATR (NT$) 0.963473
20-Day SMA (NT$) 37.994522
12-1 Month Momentum % -4.64
52-Week Range (NT$) 34.685577 - 44.82291
Shares Outstanding (Mil) 34.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio Preventive Medicine Corp Filings

Filing Date Document Date Form
No Filing Data

Bio Preventive Medicine Corp Stock Events

Financials Calendars
Event Date Price(NT$)
No Event Data

Bio Preventive Medicine Corp Frequently Asked Questions

What is Bio Preventive Medicine Corp(ROCO:6810)'s stock price today?
The current price of ROCO:6810 is NT$38.10. The 52 week high of ROCO:6810 is NT$44.82 and 52 week low is NT$34.69.
When is next earnings date of Bio Preventive Medicine Corp(ROCO:6810)?
The next earnings date of Bio Preventive Medicine Corp(ROCO:6810) is .
Does Bio Preventive Medicine Corp(ROCO:6810) pay dividends? If so, how much?
Bio Preventive Medicine Corp(ROCO:6810) does not pay dividend.

Press Release

Subject Date
No Press Release